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Insights into 6-Methylsalicylic Acid Bio-assembly by Using Chemical
Probes
James S. Parascandolo, Judith Havemann, Helen K. Potter, Fanglu Huang, Elena Riva,
Jack Connolly, Ina Wilkening, Lijiang Song, Peter F. Leadlay, and Manuela Tosin*
Abstract: Chemical probes capable of reacting with KS
(ketosynthase)-bound biosynthetic intermediates were utilized
for the investigation of the model type I iterative polyketide
synthase 6-methylsalicylic acid synthase (6-MSAS) in vivo and
in vitro. From the fermentation of fungal and bacterial 6-
MSAS hosts in the presence of chain termination probes, a full
range of biosynthetic intermediates was isolated and charac-
terized for the first time. Meanwhile, in vitro studies of
recombinant 6-MSA synthases with both nonhydrolyzable
and hydrolyzable substrate mimics have provided additional
insights into substrate recognition, providing the basis for
further exploration of the enzyme catalytic activities.
Together with peptidic molecules, polyketide natural prod-
ucts constitute one of the most abundant sources of bio-
derived and bio-inspired pharmaceuticals: these include
widely utilized antibiotic and antitumor agents (for example,
erythromycin and doxorubicin) and cholesterol-lowering
(statin) drugs.[1] Polyketide biosynthesis resembles that of
fatty acids in the use of decarboxylative Claisen condensation
to generate enzyme-bound b-keto thioester intermediates,
which are variably processed and ultimately converted to
highly diversified products in structure and function. Poly-
ketide synthases (PKSs) can be distinguished as either
modular or iterative: the former (best known as type I
modular) are assembly lines comprising multiple sets of
domains (modules), with each catalyzing at least one round of
chain extension and downstream translocation for further
processing. For these PKSs the module order and composition
determine the sequence of biosynthetic events,[2]which can be
predicted and manipulated to generate novel compounds.[3]
Conversely iterative synthases are constituted by single
enzymes (type I and III) or clusters of discrete proteins
(type II) that harbor a limited set of catalytic domains
iteratively utilized for intermediate chain growth and elabo-
ration. The rapid and unpredictable nature of substrate
processing makes the investigation of iterative synthases
much more challenging compared to their modular counter-
parts. Type I iterative polyketide synthases (iPKSs) most
closely resemble fatty acid synthases in their domain organ-
ization and modus operandi. They are typical of fungi,[4]
although an increasing number have been reported in
bacteria.[5] Type I iPKSs utilize a diverse range of acyl
building blocks (for example, acetate, hexanoate, and ben-
zoate) as starter units for polyketide chain building, and have
been classified as non-reducing (NR), partially reducing
(PR), or highly reducing (HR) according to the degree of
ketone moiety processing occurring throughout product
assembly.[4] Tailoring modifications can occur during and
after assembly to yield the final bioactive molecules.[8]
Established mechanisms of iPKS product release include
cyclization and hydrolysis mediated by thioesterase (TE) and
Claisen cyclase thioesterase (CLC-TE) domains, thioester
reduction,[4,5] pyrone formation,[6] and product transfer to
a nonribosomal peptide synthetase (NRPS) assembly line.[7]
Important mechanistic insights on iPKSs have been gathered
by the in vitro reconstitution of enzyme activity with putative
synthetic substrates,[9] by genetic manipulation,[10] and by
analysis of protein site-occupancy using advanced mass
spectrometry of PKS-bound precursors.[11] However, key
details of the timing of biosynthetic transformations and the
basis for substrate discrimination for iPKSs remain elusive,
and new tools are needed to uncover them.
6-methylsalicylic acid (6-MSA, 1, Scheme 1) was the first
polyketide to be biosynthetically investigated.[12] It is pro-
duced in various fungi including Penicillium patulum, where it
is a precursor to the toxin patulin.[13] 6-MSA is also a key
structural moiety of promising antibiotic and anticancer
agents, such as chlorothricin, maduropeptin, and neocarzi-
nostatin.[14] The iPKS 6-methysalicylic acid synthase (6-
MSAS) was first purified from P. patulum and characterized
as a 188 kDa tetrameric protein.[15] Early labeling experi-
ments established that 6-MSAS requires one acetyl-CoA (2)
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and three malonyl-CoA molecules (3, Figure 1A) to generate
6-MSA.[16] Analysis of its gene cluster revealed it encodes one
polypeptide chain harboring ketosynthase (KS), acyltransfer-
ase (AT), dehydratase (DH), ketoreductase (KR), and acyl
carrier protein (ACP) domains[17] as in a vertebrate fatty acid
synthase. Mechanistic studies of purified 6-MSAS using
substrate/intermediate analogues and enzyme inhibitors,[18]
as well as enzyme mutagenesis,[14a,19] have led to two distinct
biosynthetic proposals: in the first, DH-catalyzed dehydration
of a 3-hydroxytriketide intermediate is followed by a further
round of chain extension, trans to cis isomerization of
a double bond, aromatization, and finally thioester hydrolysis
(Scheme 1a).[18c,19a] In the second, a 3-hydroxytriketide inter-
mediate is directly extended to a 5-hydroxytetraketide, which
cyclizes, dehydrates, and aromatizes prior to final product
release (Scheme 1b).[18c,19b] A recent study of the 6-MSAS-
like enzyme ATX from Aspergillus
terreus has supported this second route
and provided evidence of involvement
of a so-called thioester hydrolase
(THID) domain in product release.[19b]
The THID domain comprises the pre-
viously identified dehydratase (DH)
domain together with an adjacent
region termed the interdomain (ID)
linker, originally identified as a core
domain required for subunit–subunit
interaction within ATX.[19a] THID has
been shown to catalyze 6-MSA release
from a mutant form of ATX (H972A,
which would inactivate the DH func-
tion); it also catalyzes hydrolysis of the
N-acetylcysteamine thioester of 6-MSA.[19b] This suggests that
enzyme-catalyzed dehydration of a 3-hydroxytriketide inter-
mediate is not necessary for 6-MSA formation. However, in
the absence of direct evidence for the biosynthetic inter-
mediates involved, it remains unclear whether triketide
dehydration takes place and whether the sole role of THID
is the hydrolytic release of enzyme-bound 6-MSA.
To obtain a complete mechanistic picture of 6-MSA
assembly, we have used chain-termination probes for the
capture and identification of polyketide intermediates.[20,21]
By competing with ACP-bound malonate extension units for
the growing polyketide chain, the chemical probes react with
enzyme-bound intermediates and off-load them for LC-MS
characterization (Figure 1). The use of these tools has already
allowed fresh insights into the timing and the mechanism of
modular assembly-line biosynthesis in vitro[20] and in vivo,[21]
Scheme 1. Overview of biosynthetic hypotheses leading to 6-methylsalicylic acid (6-MSA, 1):
a) enzymatic dehydration of a 3-hydroxytriketide followed by further chain extension leads to
a dehydrated enzyme-bound tetraketide, eventually giving 1; b) formation of a 5-hydroxytetrake-
tide eventually leading to 1 via TH-mediated hydrolysis.[18c, 19b] 6-MSAS comprises ketosynthase
(KS), acyltransferase (AT), thioester hydrolase (THID),[19b] ketoreductase (KR), and acyl carrier
protein (ACP) domains.
Figure 1. A) Chain termination probes 9–12, generated in vivo from the hydrolysis of the corresponding esters 4–8,[21] compete with ACP-bound
malonate to off-load 6-MSAS-bound intermediates in P. patulum, E. coli heterologously expressing 6-MSAS,[22] and S. antibioticus DSM40725
(Supporting Information, Tables 1S–3S); B) LC- HR-MS detection of putative hydroxytetraketides captured from P. patulum ; C) HR-MSn analyses
of a putative hydroxypentaketide resulting from the off-loading of a KS-bound hydroxytetraketide in P. patulum.
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and, more recently, has unveiled novel opportunities for the
generation of unnatural polyketide derivatives.[21c] We ini-
tially used our intermediate-capturing probes for in vivo
studies on fungal and bacterial strains harboring 6-MSAS
genes, including the natural 6-MSA producer P. patulum, an
engineered E. coli host strain heterologously expressing P.
patulum 6-MSAS (E. coli BAP1 pKOS007-109),[22] and S.
antibioticus DSM40725 (producer of chlorothricin).[14a] Each
strain was grown in the presence of substrates 4–8, which are
hydrolyzed in vivo to the corresponding carboxylates 9–12
(Figure 1A; Supporting Information, Figure 2S).[20]
The overall outcome of these in vivo experiments is
illustrated in Figure 1 (for details, see the Supporting Infor-
mation, Tables 1S–3S and following figures). In most of the
ethyl acetate extracts from both fungal and bacterial hosts,
a series of trapped intermediates, including diketides, trike-
tides, reduced triketides, and a range of putative hydroxy,
dehydrated, and aromatized tetraketides, were identified by
HR-LC-MS: these would directly reflect the nature of ACP-
bound substrates in 6-MSA assembly. Besides, putative
hydroxy, dehydrated, and aromatized pentaketides arising
from the off-loading of 6-MSAS-bound tetraketides were also
identified (Figure 1C and the Supporting Information). All
the captured intermediates, absent in control samples, were
characterized by MSn analysis, showing diagnostic peaks
resulting from the loss of N-acyl chains and subsequent cyclic
imine formation (Figure 1C and the Supporting Information).
For themajority of the putative tetraketides and pentaketides,
multiple peaks were observed: these may arise from isomer-
ization, cyclization and dehydration events which can be
spontaneous or enzyme-catalyzed. A distinction between
hydroxy, dehydrated, and aromatized advanced species was
made on the basis of variable LC retention times as well as of
detected accurate masses. On the same basis, distinct species
with masses corresponding to dehydrated triketides could not
be identified. From the lack of direct evidence for dehydrated
triketides and the identification of the putative hydroxy
tetraketides and pentaketides, it appears that, whether the
PKS is of fungal or of bacterial origin, route b) of Scheme 1 is
followed.
Nonetheless, to seek additional confirmation of these
insights and further dissect 6-MSAS catalytic activities, we
also utilized recombinant P. patulum 6-MSAS from heterol-
ogous E. coli BAP1 host strain,[23] as well as an additional
mutant form of the enzyme (6-MSAS H958A) bearing an
alanine in place of a histidine in the THID active site for in
vitro assays.[22] The capture of biosynthetic intermediates in
vitro proved much more challenging than in vivo. Using
probes 9a–b (generated from pig liver esterase- assisted
hydrolysis of 4a–b),[19b] only intermediates from two rounds of
chain extension were consistently identified in the ethyl
acetate extracts of 6-MSAS assays (Supporting Information,
Figure 43S). When recombinant 6-MSAS was primed with
acetoacetyl-CoA instead of acetyl-CoA in the attempt to
improve advanced intermediate capture, the accumulation of
a possibly dehydrated triketide was observed (Supporting
Information, Figure 46S).
To investigate whether this species could have been
enzymatically formed, a racemic 3-hydroxytriketide substrate
mimic 13 was synthesized in five steps from 4a (Supporting
Information) and tested as a substrate for both 6-MSAS and
its H958A mutant. In neither case was 13 enzymatically
dehydrated (Figure 2A; Supporting Information, Fig-
ure 47S); rather, we found that purified 13 dehydrated over
long-term storage. Surprisingly, when 6-MSAS and the
H958A mutant were incubated with the N-acetylcysteamine
thioester of 6-MSA 14, previously utilized to probe the THID
function in ATX,[12] no free 6-MSA was generated (Fig-
ure 2B; Supporting Information, Figure 48S). AnN-decanoyl
thioester analogue 15 was synthesized as an additional
substrate, with the idea of utilizing a long acyl chain to
mimic the phosphopantetheine cofactor of ACP. However, 15
was also resistant to hydrolysis by either enzyme (Supporting
Information, Figure 49S). This unexpected outcome suggests
that 6-MSAS differs fromATX in that covalent attachment of
tetraketide intermediates to the ACP or coenzyme A might
be necessary for their processing. Alternatively, this may
indicate that readily aromatized thioesters are not true
substrates for THID domains. The results reported herein
strongly point towards no enzymatic dehydration taking place
at a triketide stage of 6-MSA assembly, so loss of water must
occur at the tetraketide stage. If this is enzyme-catalyzed, the
configuration of the resulting alkene (from an R-alcohol, as
recently established for the 6-MSA-like mellein synthase)[24]
would likely be trans.On the basis of multiple peaks observed
for dehydrated tetraketides (for example, Supporting Infor-
mation, Figures 24S), it is tempting to speculate that, along
with final thioester hydrolysis, the THID might act as
a template domain to aid trans to cis double bond isomer-
ization, and/or cyclization and aromatization; however, this
remains undetermined. Amongst iPKSs with significant
homology to 6-MSAS and leading to 6-MSA related products,
the THID domain is highly conserved (Supporting Informa-
tion, Figure 50S). Its presence in non-reducing iPKSs such as
the orsellinic acid synthase supports its role in product
cyclization and release.[14a] Intriguingly, a THID is not present
in MicC, an iPKS responsible for the formation of 6-
pentasalicylic acid in micacocidin biosynthesis, whose assem-
bly allegedly proceeds similarly to that of 6-MSA.[7b,25]
Although bioinformatic analysis usefully pinpoints the sim-
Figure 2. Analytical HPLC analyses showing that: A) the synthetic
triketide mimic 13 is not dehydrated by 6-MSAS nor by its mutant 6-
MSAS H958A and B) the thioester substrates 14 and 15 are not
hydrolyzed by 6-MSAS nor by its mutant 6-MSAS H958A.
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ilarities of 6-MSAS to ATX and other iPKSs (Supporting
Information, Figure 51S), it cannot be used to infer subtle
differences in substrate recognition and processing between
these multienzymes. For this the use of chemical probes
appears a promising approach towards a fuller understanding
and exploitation of iPKS catalysis. Through the use of the
chain termination probes 9–12 we have indeed gathered the
first direct and comprehensive evidence for the course of
substrate processing on a type I iterative PKS. The probes
were successfully used in a fungal host and both Gram-
positive and Gram-negative bacteria, with the putative
intermediates providing preliminary insights into the kinetics
of 6-MSA assembly. In general, the first two rounds of chain
extension/processing appear relatively slow, whereas more
distinct differences can be observed in advanced intermediate
accumulation in the different 6-MSAS hosts (Supporting
Information, Tables 1S–3S and following analyses): these may
depend on probe efficiency and uptake to some extent, as well
as on specific kinetic programming of product assembly
within a particular host. Significantly 6-MSAS displayed
unexpected substrate flexibility, in that it was able to accept
malonate surrogates of different chain lengths and bearing
various functionalities (including alkyne and fluorine moi-
eties) at different positions and for every round of chain
extension, and also to generate novel pentaketide products.
This opens the possibility of utilizing iPKSs for the generation
of novel unnatural products employing different extender[21c]
as well as starter units.[26]
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